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Introduction: Haemophilic arthropathy is associated with muscle 
weakness and may be reduced prior to the onset of clinical arthropa-
thy. Muscle weakness is strongly correlated to reduced walking dis-
tances, slower ascent and descent of stairs, and altered joint motion 
and forces during weight bearing activities. Our aim was to develop 
a muscle strengthening exercise intervention for children that could 
be tested in a randomised clinical trial.
Methods: We conducted modified Nominal Group Technique focus 
groups with academic experts and specialist physiotherapists, and 
most importantly in consultation with patients. The exercise pro-
gramme was demonstrated to five boys with haemophilia and their 
parents. Children and parents were asked; what they thought about 
the exercises and whether they could undertake them on a regu-
lar basis, where they thought the best place was for undertaking 
them, and how they would like to receive information on the exer-
cise programme. They were also asked questions about how they 
would feel about taking part in a study testing the benefits of the 
exercises, issues around being allocated randomly into study groups, 
and what would encourage the children to continue on the exercise 
programme.
Results: Strong consensus from physiotherapists indicated the ex-
ercise programme should include exercises focused on strength, 
balance, proprioception, flexibility and mobility, and a motor 
learning component. Families noted the best place for the inter-
vention being carried out was at home and that twice per week 
would be achievable. Parents felt that in order to sustain inter-
est and motivation, it was important to build in an incentive that 
would be valued by the child. They also said that in order to find 
out whether or not the exercise programme worked, they would 
not have a problem with their child being allocated into an inter-
vention or usual care groups.
Discussion/Conclusion: Engaging clinicians and patients in part-
nership as part of the research process enhanced the design of 
an exercise intervention ensuring it is acceptable and poten-
tially beneficial for children with chronic disorders. The efficacy 
of a 24- session progressive exercise programme of stretching, 
strengthening, balance, proprioceptive and mobility using func-
tional movement patterns is currently being tested in a ran-
domised controlled trial.
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Introduction: Sacrococcygeal pilonidal sinus disease (PSD) is a 
common chronic inflammation of the natal cleft and presents as 
an abscess or a chronically discharging, painful sinus tract. It has 
an incidence of 1.2- 2.5/1000 in children. Onset is around puberty. 
Symptoms of recurrent abscess and chronic suppuration may inter-
fere with education and social integration. Treatments should cause 
minimal disruption while having good cure and recurrence rates. The 
management of chronic PSD is variable, contentious, and problem-
atic. Although many surgical procedures have been tried, the best 
surgical method remains controversial.
We presented two haemophilia patients undergoing pilonidal sinus 
surgery in our hospital.
Methods: We presented two haemophilia patients undergoing pilo-
nidal sinus surgery in our hospital.
Results: Case 1. Sixteen- year- old boy with severe haemophilia B was 
unresponsive to two- year medical treatment. Excision surgery planned 
for pilonidal sinus disease. Inhibitory test was negative. His weight 
was 50 kg. Presurgery 1800 IU plasma derived factor IX was given 
Presurgery factor IX level was 64%. Tranexamic acid was started. He 
was removed from the hospital at four days after the surgery.
Case 2. Nineteen- year- old boy with severe haemophilia A was un-
responsive to four- year medical treatment. He has family history for 
haemophilia and has intron 22 inversion mutation. Excision surgery 
planned for pilonidal sinus disease. Inhibitory test was negative. His 
weight was 90 kg. Presurgery 2000 IU recombinant factor VIII was 
given then factor level was 52%. Tranexamic acid was started. We 
give 2000 unit factor VIII was given every 24 hours, total three doses. 
He was removed from the hospital at two days after the surgery. 
Surgical procedure completed with a total of 67 IU / kg factor VIII
After then, 2000 IU prophylaxis was continued for two days a week. 
Two weeks later, there was no bleeding or discharge. Wound heal-
ing was completed. For four months after surgery, the disease was 
not repeated.
Discussion/Conclusion: There is no case series related to sacrococcy-
geal pilonidal sinus disease surgery in hemophilia patients. However, 
if surgical surgeons and hematologists cooperate and communicate 
closely, these surgical procedures can be performed successfully.
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